Disclosures: Charles N Pozner, MD Nothing to disclose. Ron M Walls, MD, FRCPC, FAAEM Other Financial Interest: Airway Management Education Center [Healthcare provider education and resources (Cook Melker Universal Cricothyrotomy kit, the Difficult Airway course)]. Richard L Page, MD Nothing to disclose. Jonathan Grayzel, MD, FAAEM Nothing to disclose.
Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are addressed by vetting through a multi-level review process, and through requirements for references to be provided to support the content. Appropriately referenced content is required of all authors and must conform to UpToDate standards of evidence.
INTRODUCTION — The field of resuscitation has been evolving for more than two centuries . The Paris Academy of Science recommended mouth-to-mouth ventilation for drowning victims in 1740 . In 1891, Dr. Friedrich Maass performed the first documented chest compressions on humans . The American Heart Association (AHA) formally endorsed cardiopulmonary resuscitation (CPR) in 1963, and by 1966, they had adopted standardized CPR guidelines for instruction to lay-rescuers .
Advanced cardiac life support (ACLS) guidelines have evolved over the past several decades based on a combination of scientific evidence of variable strength and expert consensus. The American Heart Association (AHA) developed the most recent ACLS guidelines in 2010 using the comprehensive review of resuscitation literature performed by the International Liaison Committee on Resuscitation (ILCOR) [4,5]. Guidelines are reviewed continually, but are formally released every five years, and published in the journals Circulation and Resuscitation.
This topic will discuss the management of cardiac arrhythmias in adults as described in the 2010 ACLS Guidelines. The evidence supporting these guidelines is presented separately, as are issues related to controversial treatments for cardiac arrest patients, basic life support (BLS), airway management, and post-cardiac arrest management. (See "Supportive data for advanced cardiac life support in adults with sudden cardiac arrest" and "Therapies of uncertain benefit in basic and advanced cardiac life support" and "Basic life support (BLS) in adults" and "Basic airway management in adults" and "Advanced emergency airway management in adults" and "Post-cardiac arrest management in adults".)
EVIDENCE BASED GUIDELINES — Because of the nature of resuscitation research, few randomized controlled trials have been completed in humans. Many of the recommendations in the American Heart Association’s 2010 Guidelines for advanced cardiac life support (hereafter referred to as the 2010 ACLS Guidelines) are made based upon retrospective studies, animal studies, and expert consensus . Guideline recommendations are classified according to the GRADE system . The evidence supporting the 2010 ACLS Guidelines is reviewed in detail separately. (See "Supportive data for advanced cardiac life support in adults with sudden cardiac arrest".)
PRINCIPLES OF MANAGEMENT
Excellent basic life support and its importance — Excellent cardiopulmonary resuscitation (CPR) and early defibrillation for treatable arrhythmias remain the cornerstones of basic and advanced cardiac life support (ACLS). Although the 2010 American Heart Association (AHA) Guidelines for ACLS (2010 ACLS Guidelines) suggest several revisions, including medications, electrical therapy, and monitoring, the emphasis on excellent CPR and its critical role in resuscitative efforts remains unchanged (algorithm 1 and algorithm 2 and figure 1) . We emphasize the term “excellent CPR” because anything short of this standard does not achieve adequate cerebral and coronary perfusion, thereby compromising a patient’s chances for neurologically intact survival. CPR is discussed in detail separately; key principles in the performance of ACLS are summarized in the following table (table 1). (See "Basic life support (BLS) in adults".)
In the past, clinicians frequently interrupted CPR to check for pulses, perform tracheal intubation, or obtain venous access. The 2010 ACLS Guidelines strongly recommend that every effort be made NOT to interrupt CPR; other less vital interventions (eg, tracheal intubation or administration of medications to treat arrhythmias) are made either while CPR is performed or during the briefest possible interruption. Interventions that cannot be performed while CPR is in progress (eg, defibrillation) should be performed during brief interruptions at two minute intervals (after the completion of a full cycle of CPR).
Studies in both the in-hospital and prehospital settings demonstrate that chest compressions are often performed incorrectly, inconsistently, and with excessive interruption [7-11]. Chest compressions must be of sufficient depth (at least 5 cm, or 2 inches) and rate (at least 100 per minute), and allow for complete recoil of the chest between compressions, to be effective.
A single biphasic defibrillation remains the recommended treatment for ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). CPR should be performed until the defibrillator is ready for immediate discharge and resumed immediately after the shock is given, without pausing to recheck a pulse at that moment. Interruptions in CPR (eg, for subsequent attempts at defibrillation or pulse checks) should occur no more frequently than every two minutes, and for the shortest possible duration. Key elements in the performance of manual defibrillation are described in the following table (table 2).
Patients are often over-ventilated during resuscitations, which can compromise venous return resulting in reduced cardiac output and inadequate cerebral and cardiac perfusion. A 30 to 2 compression to ventilation ratio (one cycle) is recommended in patients without advanced airways. According to the 2010 ACLS Guidelines, asynchronous ventilations at 8 to 10 per minute are administered if an endotracheal tube or extraglottic airway is in place, while continuous chest compressions are performed simultaneously . We believe that 6 to 8 ventilations per minute are sufficient in the low-flow state of cardiac resuscitation and help to prevent over-ventilation.
Resuscitation team management — The resuscitation of a sudden cardiac arrest (SCA), by its nature a low frequency, high acuity event, is often chaotic. A growing body of literature demonstrates that by employing the principles of Crisis Resource Management (CRM), adapted from the aviation industry and introduced into medical care by anesthesiologists, disorganization during resuscitation decreases and patient care improves [13-16]. Training in these principles to improve the quality of ACLS performed by healthcare clinicians is feasible and recommended .
Two principles provide the foundation for CRM: leadership and communication . Resuscitations usually involve a number of healthcare providers from different disciplines, sometimes from different areas of an institution, who may not have worked together previously. Under these circumstances, role clarity can be difficult to establish. In CRM, it is imperative that one person assumes the role of team leader . This person is responsible for the global management of the resuscitation, including: ensuring that all required tasks are carried out competently; incorporating new information and coordinating communication among all team members; developing and implementing management strategies that will maximize patient outcome; and reassessing performance throughout the resuscitation.
The team leader should avoid performing technical procedures, as performance of a task inevitably shifts attention from the primary leadership responsibilities. In circumstances where staffing is limited (eg, small community hospital), the team leader may be required to perform certain critical procedures. In these situations, leadership may be temporarily transferred to another clinician or the team leader may be forced temporarily to perform both roles, although this compromises the ability to provide proficient leadership.
In CRM, communication is organized to provide effective and efficient care. All pertinent communication goes through the team leader and the team leader shares important information with the team. When the team leader determines the need to perform a task, the request is directed to a specific team member, ideally by name. That team member verbally acknowledges the request and performs the task or, if unable to do so, informs the team leader that someone else should be assigned. Specific emphasis is placed on the assigned team member repeating back medication doses and defibrillator energy settings to the team leader. This "closed-loop" communication leads to a more orderly transfer of information and is the appropriate standard for all communication during resuscitations.
Though most decisions emanate from the team leader, a good team leader enlists the collective wisdom and experience of the entire team as needed. Extraneous personnel not involved with patient care are asked to leave in order to reduce noise and to ensure that orders from the leader and feedback from the resuscitation team can be heard clearly.
Initial management and ECG interpretation — In the 2010 ACLS Guidelines, circulation has taken a more prominent role in the initial management of cardiac arrest. The new ‘mantra’ is: circulation, airway, breathing (C-A-B). Once unresponsiveness is recognized, resuscitation begins by addressing circulation (chest compressions), followed by airway opening, and then rescue breathing. The 2010 ACLS Guidelines emphasize the importance of excellently performed, uninterrupted chest compressions and early defibrillation. Rescue breathing is performed after the initiation of excellent chest compressions and definitive airway management may be delayed if there is adequate rescue breathing without an advanced airway in place. (See 'Excellent basic life support and its importance' above and "Basic life support (BLS) in adults", section on 'Recognition of cardiac arrest'.)
In the non-cardiac arrest situation, the other initial interventions for ACLS include administering oxygen, establishing vascular access, placing the patient on a cardiac and oxygen saturation monitor, and obtaining an electrocardiogram (ECG) . Unstable patients must receive immediate care, even when data are incomplete or presumptive (algorithm 1 and algorithm 2).
Stable patients require an assessment of their electrocardiogram in order to provide appropriate treatment consistent with ACLS guidelines. Although it is best to make a definitive interpretation of the ECG prior to making management decisions, the settings in which ACLS guidelines are commonly employed require a modified, empirical approach. Such an approach is guided by the following questions:
●Is the rhythm fast or slow?
●Are the QRS complexes wide or narrow?
●Is the rhythm regular or irregular?
The answers to these questions often enable the clinician to make a provisional diagnosis and initiate appropriate therapy.
AIRWAY MANAGEMENT DURING ACLS — Ventilation is performed during CPR to maintain adequate oxygenation. The elimination of carbon dioxide is less important, while normalization of pH through hyperventilation is both dangerous and unattainable until there is return of spontaneous circulation (ROSC). However, during the first few minutes following sudden cardiac arrest (SCA), oxygen delivery to the brain is limited primarily by reduced blood flow [18,19]. Therefore, in adults, the performance of excellent chest compressions takes priority over ventilation during the initial period of basic life support. In settings with multiple rescuers or clinicians, ventilations and chest compressions are performed simultaneously. (See "Basic life support (BLS) in adults".)
Although research has yet to identify the preferred parameters for ventilation (eg, respiratory rate, tidal volume, inspired oxygen concentration), it is widely believed that a lower minute ventilation is needed for patients in cardiac arrest. Therefore, lower respiratory rates are used (the 2010 ACLS Guidelines recommend 8 to 10 breaths per minute with an advanced airway in place; we believe 6 to 8 breaths are adequate). In addition, we know that hyperventilation is harmful, as it leads to increased intrathoracic pressure, which decreases venous return and compromises cardiac output. Tidal volumes of approximately 600 mL delivered in a controlled fashion such that chest rise occurs over no more than one second is recommended in the 2010 ACLS Guidelines. (See "Basic life support (BLS) in adults", section on 'Ventilations'.)
Taking these principles into account, the 2010 ACLS Guidelines support the use of a bag-mask device or a blindly placed supraglottic airway for ventilation during the initial management of SCA, deferring placement of an endotracheal tube, unless intubation can be competently performed without interrupting chest compressions or one cannot ventilate the patient by other less invasive means. The performance of bag-mask ventilation (BMV) is described separately. (See "Basic airway management in adults".)
A blindly inserted supraglottic airway (eg, laryngeal mask airway, Combitube, laryngeal tube) can be placed without interrupting chest compressions, provides adequate ventilation in most cases, and reduces the risk of aspiration compared to bag-mask ventilation. Therefore, clinicians may prefer to ventilate with a supraglottic device while CPR is ongoing, rather than performing tracheal intubation. Supraglottic airways and tracheal intubation are discussed separately. (See "Devices for difficult emergency airway management in adults", section on 'Extraglottic devices' and "Direct laryngoscopy and tracheal intubation in adults".)
Advanced airway management using a supraglottic airway or tracheal intubation may not be the best approach for managing cardiac arrest patients in the prehospital setting. This view is supported by a prospective observational nationwide Japanese study involving 649,359 patients with sudden out-of-hospital cardiac arrest . In this study, the rate of survival with a favorable neurologic outcome was significantly lower among those managed with advanced airway techniques compared with bag-mask ventilation (1.1 versus 2.9 percent; odds ratio [OR] 0.38, 95% CI 0.36-0.39). Higher rates of survival with a favorable neurologic outcome persisted across all analyzed subgroups, including adjustments for initial rhythm, return of spontaneous circulation, bystander CPR, and additional treatments. Although this study has limitations due to its observational approach and was performed in a single country and so may not be generalizable to all settings, its size and consistent findings across all subgroup analyses support its conclusions. Other supporting evidence includes a retrospective review of registry data involving 10,691 cardiac arrest patients, which reported that patients managed in the prehospital setting with bag-mask ventilation had significantly higher rates of neurologically intact survival to hospital discharge than patients managed with either a supraglottic airway or intubation (18.6% versus 5.2% and 5.4% respectively) .
If advanced airway management is to be performed at all in prehospital cardiac arrest patients, it must be done by competent providers, require less than 10 seconds to complete without interruption of excellent chest compressions, and be used only after all other more essential resuscitative maneuvers have been initiated. Once performed, rescuers must avoid hyperventilation. In addition, unless adequate BMV cannot be performed, placement of an advanced airway should be attempted only during active chest compressions or deferred to the two minute interval (after a complete cycle of CPR) when defibrillation or patient reassessment is performed.
The 2010 ACLS Guidelines include the following additional recommendations about airway management during the performance of ACLS :
●Although evidence is lacking, it is reasonable to provide 100 percent oxygen during CPR. In patients who are successfully resuscitated, it is important to avoid hyperoxia while maintaining oxygen saturation above 94 percent. (See "Post-cardiac arrest management in adults", section on 'Mechanical ventilation'.)
●Cricoid pressure is controversial and is no longer routinely recommended during intubation. It may be useful for preventing gastric insufflation during bag-mask ventilation. These issues are discussed separately. (See "Rapid sequence intubation in adults", section on 'Protection (cricoid pressure) and positioning'.)
●Oropharyngeal and nasopharyngeal airways can be useful adjuncts. We encourage their use when performing bag-mask ventilation. (See "Basic airway management in adults", section on 'Airway adjuncts'.)
●Continuous waveform capnography (performed in addition to clinical assessment) is recommended for both confirming and monitoring correct tracheal tube placement, and for monitoring the quality of CPR and the return of spontaneous circulation. If waveform capnography is not available, a non-waveform CO2 detector may be used, in addition to clinical assessment. (See "Carbon dioxide monitoring (capnography)", section on 'Clinical applications for intubated patients'.)
MANAGEMENT OF SPECIFIC ARRHYTHMIAS
Sudden cardiac arrest
Ventricular fibrillation and pulseless ventricular tachycardia — Ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT) are nonperfusing rhythms emanating from the ventricles, for which early rhythm identification, defibrillation, and cardiopulmonary resuscitation (CPR) are the mainstays of treatment (algorithm 2 and figure 1). Early defibrillation is the most critical action in the resuscitation effort, followed by the performance of excellent CPR. Manage potentially treatable underlying causes as appropriate (table 3) .
Begin performing excellent chest compressions as soon as sudden cardiac arrest (SCA) is recognized and continue while the defibrillator is being attached. If a defibrillator is not immediately available, continue CPR until one is obtained. As soon as a defibrillator is available, attach it to the patient, charge it, then assess the rhythm, and treat appropriately (eg, defibrillate VF or pulseless VT; continue CPR if asystole or PEA). Resume CPR immediately after any shock is given. (See "Supportive data for advanced cardiac life support in adults with sudden cardiac arrest", section on 'VF and pulseless VT'.)
In the case of a witnessed cardiac arrest, perform defibrillation as quickly as possible. Decreased time to defibrillation improves the likelihood of successful conversion to a perfusing rhythm and of patient survival.
Biphasic defibrillators are recommended because of their increased efficacy at lower energy levels [22-24]. The 2010 ACLS Guidelines recommend that when employing a biphasic defibrillator clinicians use the initial dose of energy recommended by the manufacturer (120 to 200 J). If this dose is not known, the maximal dose may be used. We suggest a first defibrillation using 200 J with a biphasic defibrillator or 360 J with a monophasic defibrillator for VF or pulseless VT. It should be noted that many automated external defibrillators (AEDs) do not allow for adjustment of the shock output.
The 2010 ACLS Guidelines recommend the resumption of CPR immediately after defibrillation without rechecking for a pulse. CPR should not be interrupted to assess the rhythm, and rhythm checks and additional shocks should be performed no more frequently than every two minutes. (See "Basic life support (BLS) in adults", section on 'Phases of resuscitation' and "Basic life support (BLS) in adults", section on 'Defibrillation'.)
If VF or pulseless VT persists after at least one attempt at defibrillation and two minutes of CPR, give epinephrine (1 mg IV every three to five minutes) while CPR is performed continuously. Vasopressin (40 units IV) may replace the first or second dose of epinephrine.
Some study results have raised doubts about the benefit of epinephrine [25,26]. Other researchers theorize that high concentrations of circulating catecholamines may be harmful in patients who experience a return of spontaneous circulation (ROSC), and that lower doses of epinephrine or longer dosing intervals may be prudent when treating VF or pulseless VT [25,27,28]. However, pending more conclusive data or a formal change in ACLS protocols, we suggest giving epinephrine in accordance with the existing Guidelines. (See "Supportive data for advanced cardiac life support in adults with sudden cardiac arrest", section on 'VF or VT arrest and vasopressors'.)
Evidence suggests that antiarrhythmic drugs provide little survival benefit in refractory VF or pulseless VT. Nevertheless, the current ACLS Guidelines state that they may be used in certain situations. The timing of antiarrhythmic use is not specified. We suggest that antiarrhythmic drugs be considered after a second unsuccessful defibrillation attempt in anticipation of a third shock.
Refractory VF or pulseless VT may be caused by an acute coronary syndrome (ACS), in which case percutaneous coronary intervention can be performed if the patient is successfully resuscitated and the procedure is feasible. Note that following cardiac arrest the ECG may be insensitive for ACS; cardiology consultation is needed for patients with return of spontaneous circulation (ROSC) . Causes other than ACS can lead to SCA (table 3).
In summary, the ROSC in VF and pulseless VT hinges on early defibrillation and excellent CPR. Although, the 2010 ACLS Guidelines advocate the appropriate use of advanced airway management and treatment with specific medications, these interventions have not been shown to improve survival in SCA. Therefore, such interventions must never be initiated at the expense of performing excellent CPR and early defibrillation.
Asystole and pulseless electrical activity — Asystole is defined as a complete absence of demonstrable electrical and mechanical cardiac activity. Pulseless electrical activity (PEA) is defined as any one of a heterogeneous group of organized electrocardiographic rhythms without sufficient mechanical contraction of the heart to produce a palpable pulse or measurable blood pressure. By definition, asystole and PEA are non-perfusing rhythms requiring the initiation of excellent CPR immediately when either is present (algorithm 2).
In the 2010 ACLS Guidelines, asystole and PEA are addressed together because successful management for both depends on excellent CPR, vasopressors, and rapid reversal of underlying causes, such as hypoxia, hyperkalemia, poisoning, and hemorrhage . Asystole may be the result of a primary or secondary cardiac conduction abnormality, possibly from end-stage tissue hypoxia and metabolic acidosis, or, rarely, the result of excessive vagal stimulation. It is crucial to identify and treat potential secondary causes of asystole or PEA as rapidly as possible. Some causes (eg, tension pneumothorax, cardiac tamponade) result in ineffective CPR. Do not hesitate to perform invasive procedures to treat suspected secondary causes; if the patient is receiving CPR, there is little chance the intervention will make the situation worse. The accompanying tables describe important secondary causes of cardiac arrest (table 3).
After initiating CPR, treat reversible causes as appropriate and administer epinephrine (1 mg IV every three to five minutes). The 2010 ACLS Guidelines state that vasopressin may be given (40 units for the first 10 minutes of resuscitation) in place of the first or second epinephrine dose. As with VF and pulseless VT, evidence supporting the benefit of epinephrine in patients with asystole or PEA is limited and further study is needed. Neither asystole nor PEA responds to defibrillation. Atropine is no longer recommended for the treatment of asystole or PEA. Cardiac pacing is ineffective for cardiac arrest and not recommended in the 2010 ACLS Guidelines. (See "Supportive data for advanced cardiac life support in adults with sudden cardiac arrest".)
In summary, treatment for asystole and PEA consists of early identification and treatment of reversible causes and excellent CPR with vasopressor administration until either ROSC or a shockable rhythm occurs.
Monitoring — The 2010 ACLS Guidelines encourage the use of clinical and physiologic monitoring to optimize the performance of CPR and to detect the return of spontaneous circulation (ROSC) . Assessment and immediate feedback about important clinical parameters, such as the rate and depth of chest compressions, adequacy of chest recoil between compressions, and rate and force of ventilations, can improve CPR. End-tidal carbon dioxide (EtCO2) measurements from continuous waveform capnography accurately reflect cardiac output and cerebral perfusion pressure, and therefore the quality of CPR. Sudden, sustained increases in EtCO2 during CPR indicate a ROSC while decreasing EtCO2 during CPR may indicate inadequate compressions. (See "Carbon dioxide monitoring (capnography)", section on 'Effectiveness of CPR' and "Carbon dioxide monitoring (capnography)", section on 'Return of spontaneous circulation'.)
Data from other physiologic monitors is less likely to be available in patients with SCA, but measurements obtained from arterial and central venous catheters provide useful feedback about the quality of CPR and ROSC . Measurements of arterial relaxation provide a reasonable approximation of coronary perfusion pressure. During CPR, a reasonable goal is to maintain the arterial relaxation (or “diastole”) pressure above 20 mmHg. Central venous oxygen saturation (SCVO2) provides information about oxygen delivery and cardiac output. During CPR, a reasonable goal is to maintain SCVO2 above 30 percent.
Bradycardia — Bradycardia is defined conservatively as a heart rate below 60 beats per minute, but symptomatic bradycardia generally entails rates below 50 beats per minute. The 2010 ACLS Guidelines recommend that clinicians not intervene unless the patient exhibits evidence of inadequate tissue perfusion thought to result from the slow heart rate (algorithm 3) . Signs and symptoms of inadequate perfusion include hypotension, altered mental status, signs of shock, ongoing ischemic chest pain, and evidence of acute pulmonary edema. Hypoxemia is a common cause of bradycardia; look for signs of labored breathing (eg, increased respiratory rate, retractions, paradoxical abdominal breathing) and low oxygen saturation. Mild symptoms may not warrant treatment.
If any significant symptoms are present in the setting of bradycardia, administer atropine (if easily done) and immediately prepare to treat the patient with transcutaneous pacing or an infusion of a chronotropic agent (dopamine or epinephrine). Do not delay treatment with transcutaneous pacing or a chronotropic agent in order to give atropine.
The initial dose of atropine is 0.5 mg IV. This dose may be repeated every three to five minutes to a total dose of 3 mg. Do not give atropine if there is evidence of a high degree (second degree [Mobitz] type II or third degree) atrioventricular (AV) block . Atropine exerts its antibradycardiac effects at the AV node and is unlikely to be effective if a conduction block exists at or below the Bundle of His, or in transplanted hearts, which lack vagal innervation. Atropine may be harmful in the setting of cardiac ischemia. (See "Second degree atrioventricular block: Mobitz type II" and "Third degree (complete) atrioventricular block".)
Before using transcutaneous pacing, assess whether the patient can perceive the pain associated with this procedure and if so provide appropriate sedation and analgesia whenever possible. Infusions of dopamine are dosed at 2 to 10 mcg/kg per minute, while epinephrine is given at 2 to 10 mcg per minute. Each is titrated to the patient's response. (See "Procedural sedation in adults".)
If neither transcutaneous pacing nor infusion of a chronotropic agent resolves the patient’s symptoms, prepare for transvenous pacing and obtain expert consultation if available. Patients requiring transcutaneous or transvenous pacing also require cardiology consultation, and admission for evaluation for permanent pacemaker placement.
Common toxicologic causes of symptomatic bradycardia include supratherapeutic levels of beta-blockers, calcium channel blockers, and Digoxin. These poisonings are discussed separately. (See "Beta blocker poisoning" and "Calcium channel blocker poisoning" and "Digitalis (cardiac glycoside) poisoning".)
Approach — Tachycardia is defined as a heart rate above 100 beats per minute, but symptomatic tachycardia generally involves rates over 150 beats per minute, unless underlying ventricular dysfunction exists . Management of tachyarrhythmias is governed by the presence of clinical symptoms and signs caused by the rapid heart rate (algorithm 4).
The fundamental approach is as follows: First determine if the patient is unstable (eg, manifests ongoing ischemic chest pain, acute mental status changes, hypotension, signs of shock, or evidence of acute pulmonary edema). Hypoxemia is a common cause of tachycardia; look for signs of labored breathing (eg, increased respiratory rate, retractions, paradoxical abdominal breathing) and low oxygen saturation.
If instability is present and appears related to the tachycardia, treat immediately with synchronized cardioversion, unless the rhythm is sinus tachycardia . Some cases of supraventricular tachycardia may respond to immediate treatment with a bolus of adenosine (6 to 12 mg IV) without the need of cardioversion. Whenever possible, assess whether the patient can perceive the pain associated with cardioversion, and if so provide appropriate sedation and analgesia. (See "Procedural sedation in adults".)
In the stable patient, use the electrocardiogram (ECG) to determine the nature of the arrhythmia. In the urgent settings in which ACLS algorithms are most often employed, specific rhythm identification may not be possible. Nevertheless, by performing an orderly review of the ECG, one can determine appropriate management. Three questions provide the basis for assessing the electrocardiogram in this setting:
●Is the patient in a sinus rhythm?
●Is the QRS complex wide or narrow?
●Is the rhythm regular or irregular?
More detailed approaches to rhythm determination in tachycardia are discussed separately. (See "Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias" and "Approach to the diagnosis and treatment of wide QRS complex tachycardias" and "Overview of the acute management of tachyarrhythmias".)
Regular narrow complex — Sinus tachycardia and supraventricular tachycardia are the major causes of a regular narrow complex arrhythmia . Sinus tachycardia is a common response to fever, anemia, shock, sepsis, pain, heart failure, or any other physiologic stress. No medication is needed to treat sinus tachycardia; care is focused on treating the underlying cause. (See "Sinus tachycardia".)
Supraventricular tachycardia (SVT) is a regular tachycardia most often caused by a reentrant mechanism within the conduction system (algorithm 4). The QRS interval is usually narrow, but can be longer than 120 ms if a bundle branch block (ie, SVT with aberrancy or fixed bundle branch block) is present. Vagal maneuvers, which may block conduction through the AV node and result in interruption of the reentrant circuit, may be employed on appropriate patients while other therapies are prepared. Vagal maneuvers alone, (eg, Valsalva, carotid sinus massage) convert up to 25 percent of SVTs to sinus rhythm [31,32]. SVT refractory to vagal maneuvers is treated with adenosine [33,34]. (See "Overview of the acute management of tachyarrhythmias" and "Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias" and "Reentry and the development of cardiac arrhythmias".)
Because of its extremely short half-life, adenosine (6 to 12 mg IV) is injected as rapidly as possible into a large proximal vein, followed immediately by a 20 mL saline flush and elevation of the extremity to ensure the drug enters the central circulation before it is metabolized. If the first dose of adenosine does not convert the rhythm, a second and third dose of 12 mg IV may be given. Larger doses (eg, 18 mg IV) may be needed in patients taking theophylline or theobromine, or who consume large amounts of caffeine; smaller doses (eg, 3 mg IV) should be given to patients taking dipyridamole or carbamazepine, those with transplanted hearts, or when injecting via a central vein.
Prior to injection, warn the patient about transient side effects from adenosine, including chest discomfort, dyspnea, and flushing, and give reassurance that these effects are very brief. Perform continuous ECG recording during administration. If adenosine fails to convert the SVT, consider other etiologies for this rhythm, including atrial flutter or a non-reentrant SVT, which may become apparent on the ECG when AV nodal conduction is slowed.
If conversion attempts fail, initiate rate control with either an intravenous nondihydropyridine calcium channel blocker or a beta blocker. Agents to choose from include: diltiazem, verapamil, and a number of beta blockers, including metoprolol, atenolol, esmolol, and labetalol. (See "Control of ventricular rate in atrial fibrillation: Pharmacologic therapy", section on 'Pharmacologic treatment'.)
Irregular narrow complex — Irregular narrow-complex tachycardias may be caused by atrial fibrillation, atrial flutter with variable atrioventricular (AV) nodal conduction, multifocal atrial tachycardia (MAT), or sinus tachycardia with frequent premature atrial beats (algorithm 4). Of these, atrial fibrillation is most common .
The initial goal of treatment in stable patients is to control the heart rate using either a nondihydropyridine calcium channel blocker (diltiazem 15 to 20 mg IV over two minutes, repeat at 20 to 25 mg IV after 15 minutes, or verapamil 2.5 to 5 mg IV over two minutes followed by 5 to 10 mg IV every 15 to 30 minutes) or a beta blocker (eg, metoprolol 5 mg IV for 3 doses every two to five minutes; then up to 200 mg PO every 12 hours). The management of atrial fibrillation and SVT is discussed in detail separately. (See "Overview of atrial fibrillation" and "Rhythm control versus rate control in atrial fibrillation" and "Control of ventricular rate in atrial fibrillation: Pharmacologic therapy" and "Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias" and "Multifocal atrial tachycardia".)
Calcium channel blockers and beta-blockers may cause or worsen hypotension. Patients should be closely monitored while the drug is given, and patients at greater risk of developing severe hypotension (eg, elders) often require loading doses that are below the usual range. Combination therapy with a beta blocker and calcium channel blocker increases the risk of severe heart block.
Diltiazem is suggested in most instances for the management of acute atrial fibrillation with rapid ventricular response. Beta-blockers may also be used and may be preferred in the setting of an acute coronary syndrome. Beta-blockers are more effective for chronic rate control. For atrial fibrillation associated with hypotension, amiodarone may be used (150 mg IV over 10 minutes, followed by 1 mg/min drip for six hours, and then 0.5 mg/min), but the possibility of conversion to sinus rhythm must be considered . For atrial fibrillation associated with acute heart failure, amiodarone or digoxin may be used for rate control. Treatment of MAT includes correction of possible precipitants, such as hypokalemia and hypomagnesemia. The 2010 ACLS Guidelines recommend consultation with a cardiologist for these arrhythmias.
Cardioversion of stable patients with irregular narrow complex tachycardias should NOT be undertaken without considering the risk of embolic stroke. If the duration of atrial fibrillation is known to be less than 48 hours, the risk of embolic stroke is low, and the clinician may consider electrical or chemical cardioversion . A number of medications can be used for chemical cardioversion and the best drug varies according to clinical circumstance. The questions of whether chemical cardioversion is appropriate and which agent to select are reviewed separately.
Regular wide complex — A regular, wide-complex tachycardia is generally ventricular in etiology (algorithm 4). Aberrantly conducted supraventricular tachycardias may also be seen. Because differentiation between ventricular tachycardia (VT) and SVT with aberrancy can be difficult, assume VT is present. Treat clinically stable undifferentiated wide-complex tachycardia with antiarrhythmics or elective synchronized cardioversion .
In cases of regular, wide-complex tachycardia with a monomorphic QRS complex, adenosine may be used for diagnosis and treatment. Do NOT give adenosine to patients who are unstable or manifest wide-complex tachycardia with an irregular rhythm or a polymorphic QRS complex. Adenosine is unlikely to affect ventricular tachycardia but is likely to slow or convert SVT with aberrancy. Dosing is identical to that used for SVT. (See 'Regular narrow complex' above.)
Other antiarrhythmics that may be used to treat stable patients with regular, wide-complex tachycardia include procainamide (20 mg/min IV), amiodarone (150 mg IV given over 10 minutes, repeated as needed to a total of 2.2 g IV over the first 24 hours), and sotalol (100 mg IV over five minutes). A procainamide infusion continues until the arrhythmia is suppressed, the patient becomes hypotensive, the QRS widens 50 percent beyond baseline, or a maximum dose of 17 mg/kg is administered. Procainamide and sotalol should be avoided in patients with a prolonged QT interval. If the wide-complex tachycardia persists, in spite of pharmacologic therapy, elective cardioversion may be needed. The 2010 ACLS Guidelines recommend expert consultation for all patients with wide complex tachycardia.
SVT with aberrancy, if DEFINITIVELY identified (eg, old ECG demonstrates bundle branch block), may be treated in the same manner as narrow-complex SVT, with vagal maneuvers, adenosine, or rate control. (See 'Irregular narrow complex' above.)
Irregular wide complex — A wide complex, irregular tachycardia may be atrial fibrillation with preexcitation (eg, Wolf Parkinson White syndrome), atrial fibrillation with aberrancy (bundle branch block), or polymorphic ventricular tachycardia (VT)/torsades de pointes (algorithm 4) . Use of atrioventricular (AV) nodal blockers in wide complex, irregular tachycardia of unclear etiology may precipitate ventricular fibrillation (VF) and patient death, and is contraindicated. Such medications include beta blockers, calcium channel blockers, digoxin, and adenosine. To avoid inappropriate and possibly dangerous treatment, the 2010 ACLS Guidelines suggest assuming that any wide complex, irregular tachycardia is caused by preexcited atrial fibrillation.
Patients with a wide complex, irregular tachycardia caused by preexcited atrial fibrillation usually manifest extremely fast heart rates (generally over 200 beats per minute) and require immediate electric cardioversion. In cases where electric cardioversion is ineffective or unfeasible, or atrial fibrillation recurs, antiarrhythmic therapy with procainamide, amiodarone, or sotalol may be given. The 2010 ACLS Guidelines recommend expert consultation for all patients with wide complex tachycardia. Dosing for antiarrhythmic medications is described above. (See 'Regular wide complex' above.)
Treat polymorphic VT with emergent defibrillation. Interventions to prevent recurrent polymorphic VT include correcting underlying electrolyte abnormalities (eg, hypokalemia, hypomagnesemia) and, if a prolonged QT interval is observed or thought to exist, stopping all medications that increase the QT interval. Magnesium sulfate (2 g IV, followed by a maintenance infusion) can be given to prevent polymorphic VT associated with familial or acquired prolonged QT syndrome .
A clinically stable patient with atrial fibrillation and a wide QRS interval KNOWN to stem from a preexisting bundle branch block (ie, old ECG demonstrates preexisting block) may be treated in the same manner as a narrow-complex atrial fibrillation.
Alternative methods for medication administration — Whenever possible, ACLS medications should be given intravenously. When IV access cannot be established, intraosseous (IO) lines are safe, effective, and can be placed efficiently . Medication doses for IO administration are identical to those for IV therapy. If neither IV nor IO access can be established, some medications may be given via the tracheal tube. (See "Intraosseous infusion".)
Multiple studies have demonstrated that lidocaine, epinephrine, atropine, vasopressin, and naloxone are absorbed via the trachea ; however, the serum drug concentrations achieved using this route are unpredictable. If the patient already has peripheral, intraosseous, or central venous access, these are always the preferred routes for drug administration. When unable to obtain such access expeditiously, one may use the endotracheal tube while attempting to establish vascular or intraosseous access. At no point should excellent CPR be interrupted to obtain vascular access.
Doses for tracheal administration are 2 to 2.5 times the standard IV doses and medications should be diluted in 5 to 10 mL of sterile water or normal saline before injection down the tracheal tube.
POST-RESUSCITATION CARE — The 2010 ACLS Guidelines recommend a combination of goal-oriented interventions provided by an experienced multidisciplinary team for all cardiac arrest patients with return of spontaneous circulation . Important objectives for such care include:
●Optimizing cardiopulmonary function and perfusion of vital organs
●Managing acute coronary syndromes
●Implementing strategies to prevent and manage organ system dysfunction and injury
Management of the post-cardiac arrest patient is reviewed separately. (See "Post-cardiac arrest management in adults".)
TERMINATION OF RESUSCITATIVE EFFORTS — Determining when to stop resuscitation efforts in cardiac arrest patients is difficult, and little data exist to guide decision-making. Factors associated with poor and good outcomes are discussed in detail separately. (See "Prognosis and outcomes following sudden cardiac arrest".)
Physician survey data and clinical practice guidelines suggest that factors influencing the decision to stop resuscitative efforts include [38-42]:
●Duration of resuscitative effort >30 minutes without a sustained perfusing rhythm
●Initial electrocardiographic rhythm of asystole
●Prolonged interval between estimated time of arrest and initiation of resuscitation
●Patient age and severity of comorbid disease
●Absent brainstem reflexes
More objective endpoints of resuscitation have been proposed. Of these, the best predictor of outcome may be the end tidal CO2 level following 20 minutes of resuscitation [43-45]. End tidal CO2 values are a function of CO2 production and venous return to the right heart and pulmonary circulation. A very low end tidal CO2 (<10 mmHg) following prolonged resuscitation (>20 minutes) is a sign of absent circulation and a strong predictor of acute mortality [43-45]. It is crucial to note that low end tidal CO2 levels may also be caused by a misplaced (esophageal) endotracheal tube, and this possibility needs to be excluded before the decision is made to terminate resuscitative efforts. (See "Carbon dioxide monitoring (capnography)".)
Resuscitation in the emergency department does not appear to be superior to field resuscitation by emergency medical services (EMS) personnel. Therefore, EMS personnel should not be required to transport all victims of sudden cardiac arrest to the hospital, if further resuscitation is deemed futile [46,47].
Large, retrospective cohort studies have assessed criteria (BLS and ALS) for the prehospital termination of resuscitative efforts in cardiac arrest, initially described in the OPALS study [48,49]. Both BLS and ALS criteria demonstrated high specificity for identifying out-of-hospital cardiac arrest patients with little or no chance of survival. Studies of another clinical decision rule suggest that it too accurately predicts survival and would reduce unnecessary transports substantially if implemented [46,50].
According to a systematic review of 12 small trials, most of which studied convenience samples of patients with sudden cardiac arrest (n = 568), bedside echocardiography may be helpful for assessing prognosis . In this review, the pooled sensitivity and specificity of echocardiography to predict the return of spontaneous circulation (ROSC) were 91.6 and 80 percent respectively (95% CI for sensitivity 84.6 to 96.1%; 95% CI for specificity 76.1 to 83.6%). Of the 190 patients found to have cardiac wall motion, 98 (51.6 percent) achieved ROSC, whereas only 9 (2.4 percent) of the 378 without cardiac wall motion did so. Limitations of the individual studies prevented the authors from assessing survival to discharge or survival with good neurologic function.
The authors of this review emphasize that echocardiography results should not be the sole basis for terminating resuscitative efforts but may serve as an adjunct to clinical assessment. Bedside echocardiography must never interfere with resuscitation efforts, and should not interrupt or delay resumption of CPR, except in cases where the ultrasound is being obtained strictly to confirm absence of wall motion when a decision to terminate resuscitative efforts is imminent.
INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)
●Basics topic (see "Patient information: Ventricular fibrillation (The Basics)")
SUMMARY AND RECOMMENDATIONS
●Cardiopulmonary resuscitation (CPR) and early defibrillation for treatable arrhythmias remain the cornerstones of basic and advanced cardiac life support (ACLS). Excellent chest compressions without interruption are the key to successful CPR (table 1). (See 'Excellent basic life support and its importance' above.)
●The performance of teams providing ACLS improves when there is a single designated leader and the team practices clear, closed-loop communication. (See 'Resuscitation team management' above.)
●Begin properly performed cardiopulmonary resuscitation (CPR) immediately for any patient with suspected cardiac arrest. Other initial interventions for ACLS include administering oxygen, establishing intravenous access, placing the patient on a cardiac and oxygen saturation monitor, and obtaining an electrocardiogram (ECG). (See 'Initial management and ECG interpretation' above.)
●In adults, properly performed chest compressions take priority over ventilation during the initial period of basic life support. When ventilating the patient in cardiac arrest, give 100 percent oxygen, use low respiratory rates (approximately 8 breaths per minute), and avoid hyperventilation, which is harmful. (See 'Airway management during ACLS' above.)
●For the purposes of ACLS, ECG interpretation is guided by three questions:
•Is the rhythm fast or slow?
•Are the QRS complexes wide or narrow?
•Is the rhythm regular or irregular?
●The basic approach and important aspects of management for each arrhythmia covered by the 2010 ACLS Guidelines are discussed in the text and summarized in the accompanying algorithms (See 'Management of specific arrhythmias' above.):
•Bradycardia with pulse: (algorithm 3)
•Tachycardia with pulse: (algorithm 4)
- DeBard ML. The history of cardiopulmonary resuscitation. Ann Emerg Med 1980; 9:273.
- Highlights of the History of Cardiopulmonary Resuscitation (CPR). American Heart Association 2006. www.americanheart.org (Accessed on March 01, 2007).
- Hermreck AS. The history of cardiopulmonary resuscitation. Am J Surg 1988; 156:430.
- Field JM, Hazinski MF, Sayre MR, et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S640.
- Hazinski MF, Nolan JP, Billi JE, et al. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010; 122:S250.
- Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490.
- Valenzuela TD, Kern KB, Clark LL, et al. Interruptions of chest compressions during emergency medical systems resuscitation. Circulation 2005; 112:1259.
- Eilevstjønn J, Kramer-Johansen J, Eftestøl T, et al. Reducing no flow times during automated external defibrillation. Resuscitation 2005; 67:95.
- Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest. JAMA 2005; 293:299.
- Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial compression during automated defibrillation. Circulation 2002; 106:368.
- Abella BS, Sandbo N, Vassilatos P, et al. Chest compression rates during cardiopulmonary resuscitation are suboptimal: a prospective study during in-hospital cardiac arrest. Circulation 2005; 111:428.
- International Liaison Committee on Resuscitation. 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 2: Adult basic life support. Resuscitation 2005; 67:187.
- Blum RH, Raemer DB, Carroll JS, et al. Crisis resource management training for an anaesthesia faculty: a new approach to continuing education. Med Educ 2004; 38:45.
- Reznek M, Smith-Coggins R, Howard S, et al. Emergency medicine crisis resource management (EMCRM): pilot study of a simulation-based crisis management course for emergency medicine. Acad Emerg Med 2003; 10:386.
- Murray WB, Foster PA. Crisis resource management among strangers: principles of organizing a multidisciplinary group for crisis resource management. J Clin Anesth 2000; 12:633.
- Hunziker S, Johansson AC, Tschan F, et al. Teamwork and leadership in cardiopulmonary resuscitation. J Am Coll Cardiol 2011; 57:2381.
- DeVita MA, Schaefer J, Lutz J, et al. Improving medical emergency team (MET) performance using a novel curriculum and a computerized human patient simulator. Qual Saf Health Care 2005; 14:326.
- Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S729.
- Berg RA, Hemphill R, Abella BS, et al. Part 5: adult basic life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S685.
- Hasegawa K, Hiraide A, Chang Y, Brown DF. Association of prehospital advanced airway management with neurologic outcome and survival in patients with out-of-hospital cardiac arrest. JAMA 2013; 309:257.
- McMullan J, Gerecht R, Bonomo J, et al. Airway management and out-of-hospital cardiac arrest outcome in the CARES registry. Resuscitation 2014; 85:617.
- Martens PR, Russell JK, Wolcke B, et al. Optimal Response to Cardiac Arrest study: defibrillation waveform effects. Resuscitation 2001; 49:233.
- Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation 2000; 102:1780.
- Schwarz B, Bowdle TA, Jett GK, et al. Biphasic shocks compared with monophasic damped sine wave shocks for direct ventricular defibrillation during open heart surgery. Anesthesiology 2003; 98:1063.
- Hagihara A, Hasegawa M, Abe T, et al. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA 2012; 307:1161.
- Lin S, Callaway CW, Shah PS, et al. Adrenaline for out-of-hospital cardiac arrest resuscitation: a systematic review and meta-analysis of randomized controlled trials. Resuscitation 2014; 85:732.
- Warren SA, Huszti E, Bradley SM, et al. Adrenaline (epinephrine) dosing period and survival after in-hospital cardiac arrest: a retrospective review of prospectively collected data. Resuscitation 2014; 85:350.
- Jacobs IG, Finn JC, Jelinek GA, et al. Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial. Resuscitation 2011; 82:1138.
- Brady WJ, Swart G, DeBehnke DJ, et al. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations. Resuscitation 1999; 41:47.
- Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469.
- Lim SH, Anantharaman V, Teo WS, et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998; 31:30.
- Wen ZC, Chen SA, Tai CT, et al. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 1998; 98:2716.
- Delaney B, Loy J, Kelly AM. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med 2011; 18:148.
- Gebril A, Hawes S. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: is intravenous adenosine effective and safe in patients presenting with unstable paroxysmal supraventricular tachycardia? Emerg Med J 2012; 29:251.
- Cybulski J, Kułakowski P, Makowska E, et al. Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias. Clin Cardiol 1996; 19:563.
- Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999; 33:379.
- Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392.
- Mohr M, Bahr J, Schmid J, et al. The decision to terminate resuscitative efforts: results of a questionnaire. Resuscitation 1997; 34:51.
- Marco CA, Bessman ES, Schoenfeld CN, Kelen GD. Ethical issues of cardiopulmonary resuscitation: current practice among emergency physicians. Acad Emerg Med 1997; 4:898.
- de Vos R, Oosterom L, Koster RW, de Haan RJ. Decisions to terminate resuscitation. Resuscitation Committee. Resuscitation 1998; 39:7.
- Bailey ED, Wydro GC, Cone DC. Termination of resuscitation in the prehospital setting for adult patients suffering nontraumatic cardiac arrest. National Association of EMS Physicians Standards and Clinical Practice Committee. Prehosp Emerg Care 2000; 4:190.
- Horsted TI, Rasmussen LS, Lippert FK, Nielsen SL. Outcome of out-of-hospital cardiac arrest--why do physicians withhold resuscitation attempts? Resuscitation 2004; 63:287.
- Levine RL, Wayne MA, Miller CC. End-tidal carbon dioxide and outcome of out-of-hospital cardiac arrest. N Engl J Med 1997; 337:301.
- Grmec S, Klemen P. Does the end-tidal carbon dioxide (EtCO2) concentration have prognostic value during out-of-hospital cardiac arrest? Eur J Emerg Med 2001; 8:263.
- Ahrens T, Schallom L, Bettorf K, et al. End-tidal carbon dioxide measurements as a prognostic indicator of outcome in cardiac arrest. Am J Crit Care 2001; 10:391.
- Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination of resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006; 355:478.
- Ong ME, Jaffey J, Stiell I, et al. Comparison of termination-of-resuscitation guidelines for basic life support: defibrillator providers in out-of-hospital cardiac arrest. Ann Emerg Med 2006; 47:337.
- Stiell IG, Nesbitt LP, Pickett W, et al. The OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity. CMAJ 2008; 178:1141.
- Ruygrok ML, Byyny RL, Haukoos JS, Colorado Cardiac Arrest & Resuscitation Collaborative Study Group and the Denver Metro EMS Medical Directors. Validation of 3 termination of resuscitation criteria for good neurologic survival after out-of-hospital cardiac arrest. Ann Emerg Med 2009; 54:239.
- Morrison LJ, Verbeek PR, Zhan C, et al. Validation of a universal prehospital termination of resuscitation clinical prediction rule for advanced and basic life support providers. Resuscitation 2009; 80:324.
- Blyth L, Atkinson P, Gadd K, Lang E. Bedside focused echocardiography as predictor of survival in cardiac arrest patients: a systematic review. Acad Emerg Med 2012; 19:1119.